中国医师进修杂志
中國醫師進脩雜誌
중국의사진수잡지
CHINESE JOURNAL OF POSTGRADUATES OF MEDICINE
2011年
6期
15-18
,共4页
文继新%张兆平%顾美蓉%高宏%孙国华
文繼新%張兆平%顧美蓉%高宏%孫國華
문계신%장조평%고미용%고굉%손국화
剖宫产术%催产素%Tp-e间期%QTc间期
剖宮產術%催產素%Tp-e間期%QTc間期
부궁산술%최산소%Tp-e간기%QTc간기
Casarean section%Oxytocin%Tp-e interval%QTc interval
目的 观察和评价脊麻剖宫产时缩宫素对健康产妇Tp-e和QTc间期的影响.方法 ASA分级Ⅰ级择期剖宫产产妇40例,按随机数字表法分为缩宫素静脉推注组(静推组)和缩宫素静脉微泵组(微泵组),每组20例.在胎儿娩出后静推组55~60s静脉单次推注5%葡萄糖5ml+5 U缩宫素,微泵组10 min内静脉匀速泵注完5%葡萄糖20 ml+5 U缩宫素.记录并比较术前与脊麻后1、3、5 min,应用缩宫素后1、3、5、10min的QTc间期、Tp-e间期、平均动脉压(MAP)和心率.结果 静推组在应用缩宫素后1 min较术前心率明显增快[(89±13)次/min比(73±12)次/min],MAP显著降低[(69±12)mm Hg(1 mm Hg=0.133 kPa)比(82±13)mm Hg]和QTc间期明显延长[(426±21)ms比(405±18)ms](P<0.01);而在应用缩宫素后1、3、5min时Tp-e间期均较术前延长(P<0.01或<0.05).结论 单次较大剂量(5 U)缩宫素静脉快速推注可延长健康产妇的QTc和Tp-e间期;而Tp-e间期的延长可能更准确预测室性心律失常的发生.在处理QT间期延长综合征产妇脊麻剖宫产时,缩宫素的使用方式应慎重考虑.
目的 觀察和評價脊痳剖宮產時縮宮素對健康產婦Tp-e和QTc間期的影響.方法 ASA分級Ⅰ級擇期剖宮產產婦40例,按隨機數字錶法分為縮宮素靜脈推註組(靜推組)和縮宮素靜脈微泵組(微泵組),每組20例.在胎兒娩齣後靜推組55~60s靜脈單次推註5%葡萄糖5ml+5 U縮宮素,微泵組10 min內靜脈勻速泵註完5%葡萄糖20 ml+5 U縮宮素.記錄併比較術前與脊痳後1、3、5 min,應用縮宮素後1、3、5、10min的QTc間期、Tp-e間期、平均動脈壓(MAP)和心率.結果 靜推組在應用縮宮素後1 min較術前心率明顯增快[(89±13)次/min比(73±12)次/min],MAP顯著降低[(69±12)mm Hg(1 mm Hg=0.133 kPa)比(82±13)mm Hg]和QTc間期明顯延長[(426±21)ms比(405±18)ms](P<0.01);而在應用縮宮素後1、3、5min時Tp-e間期均較術前延長(P<0.01或<0.05).結論 單次較大劑量(5 U)縮宮素靜脈快速推註可延長健康產婦的QTc和Tp-e間期;而Tp-e間期的延長可能更準確預測室性心律失常的髮生.在處理QT間期延長綜閤徵產婦脊痳剖宮產時,縮宮素的使用方式應慎重攷慮.
목적 관찰화평개척마부궁산시축궁소대건강산부Tp-e화QTc간기적영향.방법 ASA분급Ⅰ급택기부궁산산부40례,안수궤수자표법분위축궁소정맥추주조(정추조)화축궁소정맥미빙조(미빙조),매조20례.재태인면출후정추조55~60s정맥단차추주5%포도당5ml+5 U축궁소,미빙조10 min내정맥균속빙주완5%포도당20 ml+5 U축궁소.기록병비교술전여척마후1、3、5 min,응용축궁소후1、3、5、10min적QTc간기、Tp-e간기、평균동맥압(MAP)화심솔.결과 정추조재응용축궁소후1 min교술전심솔명현증쾌[(89±13)차/min비(73±12)차/min],MAP현저강저[(69±12)mm Hg(1 mm Hg=0.133 kPa)비(82±13)mm Hg]화QTc간기명현연장[(426±21)ms비(405±18)ms](P<0.01);이재응용축궁소후1、3、5min시Tp-e간기균교술전연장(P<0.01혹<0.05).결론 단차교대제량(5 U)축궁소정맥쾌속추주가연장건강산부적QTc화Tp-e간기;이Tp-e간기적연장가능경준학예측실성심률실상적발생.재처리QT간기연장종합정산부척마부궁산시,축궁소적사용방식응신중고필.
Objective To evaluate the effect of oxytocin on Tp-e and QTc interval during caesarean section under spinal anesthesia in healthy puerperas. Methods Forty ASA Ⅰ puerperas were selected and allocated to receive oxytocin intravenous bolus group (group-IB) or oxytocin continuous infusion group (group-CI) with 20 puerperas in each by random digits table. An intravenous bolus of 5% glucose 5 ml and 5 U oxytocin was administered after delivery a 55-60 s period. A continuous infusion of 5% glucose 5 ml and 5U oxytocin was administered after delivery a 10 min period. Measured the QTc interval,Tp-e interval,mean arterial pressure (MAP) and beart rate ( HR ) pre-operatively, then 1,3 and 5 ain after spinal anesthesia, and at least 1,3,5 and 10 min after oxytocin injection. Results In group-IB:HR was fast 1 min after oxytocin injection compared with pre-operatively [(89 ± 13) beats/min vs. (73 ± 12) beats/min] ,MAP was decreased [(69 ± 12 ) mm Hg ( 1 mm Hg= 0. 133 kPa ) vs. ( 82 ± 13 ) mm Hg] and QTc interval was prolonged [(426 ±21 ) ms vs. (405 ± 18 ) ms] (P < 0.01 ); but Tp-e interval was prolonged 1,3,5 min after oxytocin injection compared with pre-operatively (P < 0.01 or < 0.05 ). Conclusions Single large dose of oxytocin intravenous bolus (5 U) can prolong QTc interval and Tp-e interval in healthy puerperas, and Tp-e interval can exact predict the occurrence of ventricular arrhythmias. The risk-benefit balance of oxytocin bolus during caesarean delivery should be discussed with women with a history of long QT syndrome.